Hemangioma
ICD-10 D18.0 is a billable code used to indicate a diagnosis of hemangioma.
Hemangiomas are benign vascular tumors characterized by an abnormal proliferation of blood vessels. They are most commonly found in infants and children, often appearing as red or purple marks on the skin. Hemangiomas can occur in various locations, including the skin, liver, and other organs. While many hemangiomas resolve spontaneously over time, some may require medical intervention if they cause complications such as ulceration, bleeding, or functional impairment. Surveillance is essential for hemangiomas that are large, located near vital structures, or symptomatic, as they may have the potential for complications. Although hemangiomas are benign, there is a need for careful monitoring to ensure they do not progress or lead to significant health issues. In rare cases, atypical hemangiomas may exhibit aggressive behavior, necessitating further evaluation to rule out malignancy. Overall, the management of hemangiomas involves a multidisciplinary approach, including pediatricians, dermatologists, and, when necessary, surgical specialists.
Detailed history of the hemangioma, including onset, size, location, and any complications.
Infants presenting with cutaneous hemangiomas requiring monitoring or intervention.
Consideration of growth patterns and potential for regression.
Photographic evidence of hemangioma, treatment plans, and follow-up notes.
Adult patients with residual hemangiomas or those requiring cosmetic intervention.
Differentiation from other vascular lesions and documentation of treatment outcomes.
Used when a hemangioma requires surgical intervention.
Document the size, location, and reason for destruction.
Ensure alignment with dermatology guidelines for lesion management.
Management may include observation, medical treatment with beta-blockers, or surgical intervention if complications arise.
